Related Experiment Video
Updated: Dec 19, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
Research status and development potential of composite hemostatic materials
Caiyun Zheng1, Qingyan Zeng1, SaHu Pimpi1
1School of Life Sciences, Northwestern Polytechnical University, 127 West Youyi Road, Beilin District, Xi'an Shaanxi, 710072, P. R. China. lutinglixinxin@nwpu.edu.cn.
New composite hemostatic materials aim to improve bleeding control by activating multiple coagulation mechanisms. Future research should focus on biocompatibility, shape variability, and in vivo degradability for enhanced hemostasis.
Area of Science:
- Biomaterials Science
- Hemostasis Research
- Wound Healing
Background:
- Bleeding is a critical medical issue requiring effective hemostasis for survival and wound healing.
- Current hemostatic materials activate coagulation through physical barriers, platelet aggregation, or clotting factor release.
- There is a need for advanced hemostatic materials with improved properties.
Purpose of the Study:
- To review the current state of composite hemostatic materials.
- To discuss mechanisms of action for hemostatic materials.
- To propose future directions for the development of advanced hemostatic materials.
Main Methods:
- Literature review of composite hemostatic materials.
- Analysis of coagulation mechanisms activated by hemostatic agents.
- Discussion of material characteristics and their impact on hemostasis.
Main Results:
- Composite hemostatic materials offer enhanced efficacy by activating multiple coagulation pathways.
- Existing materials often lack ideal characteristics such as biocompatibility, shape adaptability, and in vivo degradability.
- Simultaneous activation of various clotting mechanisms is key to superior hemostatic performance.
Conclusions:
- Future composite hemostatic materials should prioritize high biocompatibility, shape variability, and in vivo degradability.
- Materials capable of addressing both internal and external bleeding are desirable.
- Further research into camouflaging properties and clotting factor release is recommended for optimized hemostatic materials.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

